A 13G filing indicates a passive investment but also reflects a substantial ownership in the company. This level of investment from a firm like Commodore Capital LP can be seen as a vote of confidence in C4 Therapeutics, which may lead to increased investor interest and a potential short-term positive impact on the stock price. However, as the stake is passive, it does not imply active management or changes in company strategy.